Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
INZY | Inozyme Pharma, Inc. | Interim CFO | May 17, 2021 | |||
SPRO | Spero Therapeutics, Inc. | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney | Jul 15, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|